GC announces its launch of a Norwegian subsidiary located in Steinkjer’s innovation campus, InnoCamp.
GC’s focus in Norway will be to strengthen partnerships and further develop and commercialise our patented and patent pending solutions in health, ballistic protection, energy, and composites. The aim is to grow the company, to become a valuable partner in the Norwegian market, and meet the region’s future needs and those of the rest of Europe.
Steinkjer is in Trøndelag, a region renowned for being a knowledge and innovation hub; its excellent research facilities and funding initiatives, particularly in the fields of science, energy, and health, are a major draw for many international organisations.
GC Norway will primarily concentrate on the commercialisation of GC Ink™, a patent pending graphene oxide and silver nanoparticle formulation with a proven ability to kill viruses and bacteria. The ink establishes a virucidal layer on fabrics and has been independently tested and ISO certified to have at least 99% virucidal efficacy when applied as a coating to filter materials. Fast-acting, effective, and safe, GC Ink successfully traps and kills airborne coronaviruses and other pathogens, including influenza.
GC is already collaborating with some Norwegian organisations and is using Norwegian-produced graphene of the highest quality. GC is pleased to have established a partnership with SINTEF. The competence SINTEF brings, and pioneering research institute, offering world-leading laboratory and test facilities, will be valuable in supporting the development and commercialisation of GC Ink.
“We were attracted to Norway’s stable society and strong economy, its high level of education, and the significant technology and research innovation capabilities available in the country,” said Sandy Chen, GC CEO & Co-Founder.“As demand for GC Ink rises, GC Norway is well-positioned to scale production to meet demand across Norway, and the rest of Europe. Working with partners builds on this strategy, strengthening our supply chain and key collaborative relationships in the region. We are excited about this development and are keen to hear from other organisations interested in joining with us to explore new opportunities for nanomaterials to help solve key technical challenges.”
Senior Scientist at SINTEF, Dr. Branson Belle, said, “We are very excited to see GC establish a subsidiary here in Norway. With our advanced characterisation laboratories and competence, SINTEF is well-positioned to support GC in its further development”.
Kyrre Haugen, General Manager at the Norwegian British Chamber of Commerce says “It is exciting to see GC establish a footing in Norway with opportunities to leverage its unique nanotechnology with the excellent research & development facilities and services that Norway can provide – ultimately strengthening the trade and investment between Norway and the UK. We look forward to supporting their growth and anticipate great things for the future”.